Emerging infectious diseases: a 10-year perspective from the National Institute of Allergy and Infectious Diseases.
Identifieur interne : 000E92 ( Ncbi/Merge ); précédent : 000E91; suivant : 000E93Emerging infectious diseases: a 10-year perspective from the National Institute of Allergy and Infectious Diseases.
Auteurs : Anthony S. Fauci [États-Unis] ; Nancy A. Touchette ; Gregory K. FolkersSource :
- Emerging infectious diseases [ 1080-6040 ] ; 2005.
Descripteurs français
- KwdFr :
- Bioterrorisme, Fièvre à virus West Nile (épidémiologie), Grippe humaine (épidémiologie), Humains, Infections à VIH (épidémiologie), Maladie du charbon (épidémiologie), Maladies transmissibles émergentes (épidémiologie), National Institutes of Health (USA) (économie), Paludisme (épidémiologie), Santé mondiale, Syndrome respiratoire aigu sévère (épidémiologie), Tuberculose (épidémiologie), États-Unis d'Amérique.
- MESH :
- économie : National Institutes of Health (USA).
- épidémiologie : Fièvre à virus West Nile, Grippe humaine, Infections à VIH, Maladie du charbon, Maladies transmissibles émergentes, Paludisme, Syndrome respiratoire aigu sévère, Tuberculose.
- Bioterrorisme, Humains, Santé mondiale, États-Unis d'Amérique.
- Wicri :
- geographic : États-Unis.
English descriptors
- KwdEn :
- Anthrax (epidemiology), Bioterrorism, Communicable Diseases, Emerging (epidemiology), Global Health, HIV Infections (epidemiology), Humans, Influenza, Human (epidemiology), Malaria (epidemiology), National Institutes of Health (U.S.) (economics), Severe Acute Respiratory Syndrome (epidemiology), Tuberculosis (epidemiology), United States, West Nile Fever (epidemiology).
- MESH :
- geographic : United States.
- economics : National Institutes of Health (U.S.).
- epidemiology : Anthrax, Communicable Diseases, Emerging, HIV Infections, Influenza, Human, Malaria, Severe Acute Respiratory Syndrome, Tuberculosis, West Nile Fever.
- Bioterrorism, Global Health, Humans.
Abstract
Although optimists once imagined that serious infectious disease threats would by now be conquered, newly emerging (e.g., severe acute respiratory syndrome [SARS]), reemerging (e.g., West Nile virus), and even deliberately disseminated infectious diseases (e.g., anthrax bioterrorism) continue to appear throughout the world. Over the past decade, the global effort to identify and characterize infectious agents, decipher the underlying pathways by which they cause disease, and develop preventive measures and treatments for many of the world's most dangerous pathogens has resulted in considerable progress. Intramural and extramural investigators supported by the National Institute of Allergy and Infectious Diseases (NIAID) have contributed substantially to this effort. This overview highlights selected NIAID-sponsored research advances over the past decade, with a focus on progress in combating HIV/AIDS, malaria, tuberculosis, influenza, SARS, West Nile virus, and potential bioterror agents. Many basic research discoveries have been translated into novel diagnostics, antiviral and antimicrobial compounds, and vaccines, often with extraordinary speed.
DOI: 10.3201/eid1104.041167
PubMed: 15829188
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002793
- to stream PubMed, to step Curation: 002793
- to stream PubMed, to step Checkpoint: 002730
Links to Exploration step
pubmed:15829188Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Emerging infectious diseases: a 10-year perspective from the National Institute of Allergy and Infectious Diseases.</title>
<author><name sortKey="Fauci, Anthony S" sort="Fauci, Anthony S" uniqKey="Fauci A" first="Anthony S" last="Fauci">Anthony S. Fauci</name>
<affiliation wicri:level="1"><nlm:affiliation>National Institutes of Health, Bethesda, Maryland 20892, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>National Institutes of Health, Bethesda, Maryland 20892</wicri:regionArea>
<wicri:noRegion>Maryland 20892</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Touchette, Nancy A" sort="Touchette, Nancy A" uniqKey="Touchette N" first="Nancy A" last="Touchette">Nancy A. Touchette</name>
</author>
<author><name sortKey="Folkers, Gregory K" sort="Folkers, Gregory K" uniqKey="Folkers G" first="Gregory K" last="Folkers">Gregory K. Folkers</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:15829188</idno>
<idno type="pmid">15829188</idno>
<idno type="doi">10.3201/eid1104.041167</idno>
<idno type="wicri:Area/PubMed/Corpus">002793</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002793</idno>
<idno type="wicri:Area/PubMed/Curation">002793</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002793</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002730</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002730</idno>
<idno type="wicri:Area/Ncbi/Merge">000E92</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Emerging infectious diseases: a 10-year perspective from the National Institute of Allergy and Infectious Diseases.</title>
<author><name sortKey="Fauci, Anthony S" sort="Fauci, Anthony S" uniqKey="Fauci A" first="Anthony S" last="Fauci">Anthony S. Fauci</name>
<affiliation wicri:level="1"><nlm:affiliation>National Institutes of Health, Bethesda, Maryland 20892, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>National Institutes of Health, Bethesda, Maryland 20892</wicri:regionArea>
<wicri:noRegion>Maryland 20892</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Touchette, Nancy A" sort="Touchette, Nancy A" uniqKey="Touchette N" first="Nancy A" last="Touchette">Nancy A. Touchette</name>
</author>
<author><name sortKey="Folkers, Gregory K" sort="Folkers, Gregory K" uniqKey="Folkers G" first="Gregory K" last="Folkers">Gregory K. Folkers</name>
</author>
</analytic>
<series><title level="j">Emerging infectious diseases</title>
<idno type="ISSN">1080-6040</idno>
<imprint><date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anthrax (epidemiology)</term>
<term>Bioterrorism</term>
<term>Communicable Diseases, Emerging (epidemiology)</term>
<term>Global Health</term>
<term>HIV Infections (epidemiology)</term>
<term>Humans</term>
<term>Influenza, Human (epidemiology)</term>
<term>Malaria (epidemiology)</term>
<term>National Institutes of Health (U.S.) (economics)</term>
<term>Severe Acute Respiratory Syndrome (epidemiology)</term>
<term>Tuberculosis (epidemiology)</term>
<term>United States</term>
<term>West Nile Fever (epidemiology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Bioterrorisme</term>
<term>Fièvre à virus West Nile (épidémiologie)</term>
<term>Grippe humaine (épidémiologie)</term>
<term>Humains</term>
<term>Infections à VIH (épidémiologie)</term>
<term>Maladie du charbon (épidémiologie)</term>
<term>Maladies transmissibles émergentes (épidémiologie)</term>
<term>National Institutes of Health (USA) (économie)</term>
<term>Paludisme (épidémiologie)</term>
<term>Santé mondiale</term>
<term>Syndrome respiratoire aigu sévère (épidémiologie)</term>
<term>Tuberculose (épidémiologie)</term>
<term>États-Unis d'Amérique</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>United States</term>
</keywords>
<keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>National Institutes of Health (U.S.)</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Anthrax</term>
<term>Communicable Diseases, Emerging</term>
<term>HIV Infections</term>
<term>Influenza, Human</term>
<term>Malaria</term>
<term>Severe Acute Respiratory Syndrome</term>
<term>Tuberculosis</term>
<term>West Nile Fever</term>
</keywords>
<keywords scheme="MESH" qualifier="économie" xml:lang="fr"><term>National Institutes of Health (USA)</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Fièvre à virus West Nile</term>
<term>Grippe humaine</term>
<term>Infections à VIH</term>
<term>Maladie du charbon</term>
<term>Maladies transmissibles émergentes</term>
<term>Paludisme</term>
<term>Syndrome respiratoire aigu sévère</term>
<term>Tuberculose</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Bioterrorism</term>
<term>Global Health</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Bioterrorisme</term>
<term>Humains</term>
<term>Santé mondiale</term>
<term>États-Unis d'Amérique</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>États-Unis</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Although optimists once imagined that serious infectious disease threats would by now be conquered, newly emerging (e.g., severe acute respiratory syndrome [SARS]), reemerging (e.g., West Nile virus), and even deliberately disseminated infectious diseases (e.g., anthrax bioterrorism) continue to appear throughout the world. Over the past decade, the global effort to identify and characterize infectious agents, decipher the underlying pathways by which they cause disease, and develop preventive measures and treatments for many of the world's most dangerous pathogens has resulted in considerable progress. Intramural and extramural investigators supported by the National Institute of Allergy and Infectious Diseases (NIAID) have contributed substantially to this effort. This overview highlights selected NIAID-sponsored research advances over the past decade, with a focus on progress in combating HIV/AIDS, malaria, tuberculosis, influenza, SARS, West Nile virus, and potential bioterror agents. Many basic research discoveries have been translated into novel diagnostics, antiviral and antimicrobial compounds, and vaccines, often with extraordinary speed.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15829188</PMID>
<DateCompleted><Year>2005</Year>
<Month>05</Month>
<Day>11</Day>
</DateCompleted>
<DateRevised><Year>2018</Year>
<Month>11</Month>
<Day>13</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">1080-6040</ISSN>
<JournalIssue CitedMedium="Print"><Volume>11</Volume>
<Issue>4</Issue>
<PubDate><Year>2005</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>Emerging infectious diseases</Title>
<ISOAbbreviation>Emerging Infect. Dis.</ISOAbbreviation>
</Journal>
<ArticleTitle>Emerging infectious diseases: a 10-year perspective from the National Institute of Allergy and Infectious Diseases.</ArticleTitle>
<Pagination><MedlinePgn>519-25</MedlinePgn>
</Pagination>
<Abstract><AbstractText>Although optimists once imagined that serious infectious disease threats would by now be conquered, newly emerging (e.g., severe acute respiratory syndrome [SARS]), reemerging (e.g., West Nile virus), and even deliberately disseminated infectious diseases (e.g., anthrax bioterrorism) continue to appear throughout the world. Over the past decade, the global effort to identify and characterize infectious agents, decipher the underlying pathways by which they cause disease, and develop preventive measures and treatments for many of the world's most dangerous pathogens has resulted in considerable progress. Intramural and extramural investigators supported by the National Institute of Allergy and Infectious Diseases (NIAID) have contributed substantially to this effort. This overview highlights selected NIAID-sponsored research advances over the past decade, with a focus on progress in combating HIV/AIDS, malaria, tuberculosis, influenza, SARS, West Nile virus, and potential bioterror agents. Many basic research discoveries have been translated into novel diagnostics, antiviral and antimicrobial compounds, and vaccines, often with extraordinary speed.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fauci</LastName>
<ForeName>Anthony S</ForeName>
<Initials>AS</Initials>
<AffiliationInfo><Affiliation>National Institutes of Health, Bethesda, Maryland 20892, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Touchette</LastName>
<ForeName>Nancy A</ForeName>
<Initials>NA</Initials>
</Author>
<Author ValidYN="Y"><LastName>Folkers</LastName>
<ForeName>Gregory K</ForeName>
<Initials>GK</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Emerg Infect Dis</MedlineTA>
<NlmUniqueID>9508155</NlmUniqueID>
<ISSNLinking>1080-6040</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000881" MajorTopicYN="N">Anthrax</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D023482" MajorTopicYN="N">Bioterrorism</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D021821" MajorTopicYN="N">Communicable Diseases, Emerging</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014943" MajorTopicYN="N">Global Health</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008288" MajorTopicYN="N">Malaria</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009316" MajorTopicYN="N">National Institutes of Health (U.S.)</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014376" MajorTopicYN="N">Tuberculosis</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014901" MajorTopicYN="N">West Nile Fever</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2005</Year>
<Month>4</Month>
<Day>15</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2005</Year>
<Month>5</Month>
<Day>12</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2005</Year>
<Month>4</Month>
<Day>15</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">15829188</ArticleId>
<ArticleId IdType="pmc">PMC3320336</ArticleId>
<ArticleId IdType="doi">10.3201/eid1104.041167</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Clin Infect Dis. 2001 Mar 1;32(5):675-85</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11229834</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dis. 2005 Mar 1;191(5):647-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15688276</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2001 Jul-Aug;7(4):759</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11585547</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2002 Oct 4;298(5591):129-49</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12364791</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2002 Oct 4;298(5591):210-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12364805</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2002 Oct 3;419(6906):498-511</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12368864</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Emerg Infect Dis. 2002 Oct;8(10):1019-28</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12396909</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Infect Immun. 2003 Apr;71(4):1672-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12654780</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Tuberculosis (Edinb). 2003;83(1-3):213-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12758214</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2003 Jun 27;300(5628):2036-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12829768</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Med. 2003 Jul;9(7):839-43</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12835701</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2003 Aug 7;424(6949):681-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12904795</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Exp Biol. 2003 Nov;206(Pt 21):3869-75</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14506222</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MMWR Recomm Rep. 2003 Sep 26;52(RR-13):1-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14557799</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Adv Virus Res. 2003;61:185-234</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14714433</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2004 Mar 11;428(6979):182-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15014500</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Virol. 2004 Apr;78(7):3572-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15016880</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2004 Apr 1;428(6982):561-4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15024391</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2004 Apr 3;363(9415):1099-103</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15064027</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4590-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15070762</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Vector Borne Dis. 2003 Sep-Dec;40(3-4):73-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15119075</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6641-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15096611</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Drug Discov. 2004 Jun;3(6):509-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15173840</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Expert Opin Biol Ther. 2004 Jun;4(6):965-73</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15174978</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Immunol. 2004 Jun 15;172(12):7618-28</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15187142</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Tuberculosis (Edinb). 2004;84(3-4):131-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15207482</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2004 Jun 26;363(9427):2122-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15220033</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2004 Jul 8;430(6996):242-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15241422</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Clin Microbiol. 2004 Jul;42(7):2913-8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15243038</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Expert Opin Biol Ther. 2004 Aug;4(8):1295-305</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15268663</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Med. 2004 Aug;10(8):871-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15247913</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mol Cell. 2004 Sep 24;15(6):867-77</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15383277</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nature. 2004 Oct 7;431(7009):703-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15470432</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2004 Oct 16-22;364(9443):1411-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15488216</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Bull World Health Organ. 1969;41(3):589-94</Citation>
<ArticleIdList><ArticleId IdType="pubmed">5309481</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Science. 2001 Sep 7;293(5536):1840-2</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11546875</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>États-Unis</li>
</country>
</list>
<tree><noCountry><name sortKey="Folkers, Gregory K" sort="Folkers, Gregory K" uniqKey="Folkers G" first="Gregory K" last="Folkers">Gregory K. Folkers</name>
<name sortKey="Touchette, Nancy A" sort="Touchette, Nancy A" uniqKey="Touchette N" first="Nancy A" last="Touchette">Nancy A. Touchette</name>
</noCountry>
<country name="États-Unis"><noRegion><name sortKey="Fauci, Anthony S" sort="Fauci, Anthony S" uniqKey="Fauci A" first="Anthony S" last="Fauci">Anthony S. Fauci</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E92 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000E92 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= Ncbi |étape= Merge |type= RBID |clé= pubmed:15829188 |texte= Emerging infectious diseases: a 10-year perspective from the National Institute of Allergy and Infectious Diseases. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:15829188" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |